SO
ATXI

STRS Ohio’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

STRS Ohio’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$10K – 2294
2020
Q4 		$10K Hold
2
– – ﹤0.01% 2109
2020
Q3 		$18K Hold
2
– – ﹤0.01% 2101
2020
Q2 		$18K Buy
+2
New +$22.6K ﹤0.01% 2057

Other funds holding ATXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

STRS Ohio's ATXI Position: Q1 2021 in Review

STRS Ohio sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q1 2021, closing a stake of 2 shares — an estimated $10K sold.

STRS Ohio first reported a position in ATXI in Q2 2020 and held it in 3 quarters. The position peaked at $18K in Q3 2020. 30 funds tracked by Wall St. Rank hold ATXI as of Q1 2021.

  • STRS Ohio reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • STRS Ohio sold 2 Avenue Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $10K.
  • STRS Ohio first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • STRS Ohio's Avenue Therapeutics, Inc. Common Stock position peaked at $18K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.